跳至主要内容
临床试验/NCT07288606
NCT07288606
进行中(未招募)
不适用

Marginal Bone Loss in Implants Placed in Bone Level and Tissue Level

University of Barcelona1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年12月2日最近更新:

概览

阶段
不适用
状态
进行中(未招募)
入组人数
20
试验地点
1
主要终点
Torque

概览

简要总结

It is a prospective clinical study to compare two implants of the same brand of a similar design for implantation [either at the bone tissue level or at the soft tissue level], in order to evaluate the marginal bone loss of each dental implant in mm. 96 patients will be analyzed (an expected N of 48 per group, hoping to reach 100 implants per arm).

详细描述

it is a study to evualte the marginal bone loss in bone level and tissue level dental implants

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients of both sexes, over 18 years of age, who need dental implant placement for prosthetic rehabilitation. Whether partially or completely in both the maxilla and the mandible.
  • Patients with residual alveolar ridge with at least 8 mm of bone height and 4 mm of width.
  • Patients must have the ability to understand and decide when voluntarily signing the informed consent before carrying out any intervention related to the study.
  • Patients who, after being informed about the objectives and procedures of the research, agree will sign the informed consent form. And they are ready to carry out the different study visits.

排除标准

  • Patients with uncontrolled systemic diseases (ASA ≥ III).
  • Patients who do not have 8mm bone height and/or 4mm width
  • Patients who require bone regeneration
  • Patients with severe periodontal disease or acute pericoronitis.
  • Pregnant and breastfeeding women.
  • Patients with Deficient or Inadequate Oral Hygiene.
  • Patients with severe bruxism.
  • Patients taking bisphosphonates or other antiresority medications.
  • Smoker of more than 10 cigarettes/day.
  • Patients with uncontrolled diabetes mellitus.

研究组 & 干预措施

Bone Level

Experimental

Placement of a bone-level dental implant. The implant-abutment interface is at the level of the alveolar bone crest.

干预措施: Dental implant placement (Procedure)

Tissue Level

Active Comparator

Placement of a tissue-level dental implant. The implant-abutment interface is located supracrestally, at the level of the soft tissue.

干预措施: Dental implant placement (Procedure)

结局指标

主要结局

Torque

时间窗: up to 24 weeks

N·cm

marginal bone loss

时间窗: 6 months

mm

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

José López Lopez

Director

University of Barcelona

研究点 (1)

Loading locations...

相似试验